Market Exclusive

Analyst Activity – SunTrust Banks Raises Its Price Target On Global Blood Therapeutics (NASDAQ:GBT) to

Analyst Ratings For Global Blood Therapeutics (NASDAQ:GBT)

Today, SunTrust Banks raised its price target on Global Blood Therapeutics (NASDAQ:GBT) to per share.

Some recent analyst ratings include

Recent Insider Trading Activity For Global Blood Therapeutics (NASDAQ:GBT)
Global Blood Therapeutics (NASDAQ:GBT) has insider ownership of 5.30% and institutional ownership of 87.81%.

Recent Trading Activity for Global Blood Therapeutics (NASDAQ:GBT)
Shares of Global Blood Therapeutics closed the previous trading session at 56.55 down -2.10 3.58% with 59.54999923706055 shares trading hands.

Exit mobile version